Age-specific incidence of breast cancer subtypes: Understanding the black-white crossover

Journal of the National Cancer Institute

Volumn 104, Issue 14, 2012, Pages 1094-1101

  Clarke, Christina A ^a   Keegan, Theresa H M ^a   Yang, Juan ^a   Press, David J ^a   Kurian, Allison W ^a   Patel, Anish H ^a   Lacey, James V ^a  

^a CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; ASIAN; CALCULATION; CANCER INCIDENCE; CANCER INVASION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSSING OVER; ETHNICITY; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TRIPLE NEGATIVE BREAST CANCER; UNITED STATES;

EID: 84864421010     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs264     Document Type: Article

References (47)

1. Anderson WF, Rosenberg PS, Menashe I, et al. Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst. 2008;100(24):1804-1814.
2. Brinton LA, Sherman ME, Carreon JD, et al. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008;100(22):1643-1648.
3. Joslyn SA, Foote ML, Nasseri K, et al. Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project. Breast Cancer Res Treat. 2005;92(2):97-105.
4. Krieger N. Social class and the black/white crossover in the age-specific incidence of breast cancer: A study linking census-derived data to population- based registry records. Am J Epidemiol. 1990;131(5):804-814.
5. Parise CA, Bauer KR, Brown MM, et al. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast J. 2009;15(6):593-602.
6. Natarajan N, Nemoto T, Mettlin C, et al. Race-related differences in breast cancer patients results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer. 1985;56(7):1704-1709.
7. Pegoraro RJ, Karnan V, Nirmul D, et al. Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res. 1986;46(4, pt 2):2117-2120.
8. Elledge RM, Clark GM, Chamness GC, et al. Tumor biologic factors and breast cancer prognosis among white, hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86(9):705-712.
9. Joslyn SA. Hormone receptors in breast cancer: Racial differences in distribution and survival. Breast Cancer Res Treat. 2002;73(1):45-59.
10. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients. Cancer. 2007;110(4):876-884.
11. Pathak DR, Osuch JR, He J. Breast carcinoma etiology: Current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer. 2000;88(Suppl 5):1230-1238.
12. Anderson WF, Reiner AS, Matsuno RK, et al. Shifting breast cancer trends in the United States. J Clin Oncol. 2007;25(25):3923-3929.
13. Bernstein L, Lacey JV. Receptors, associations, and risk factor differences by breast cancer subtypes: Positive or negative? J Natl Cancer Inst. 2011;103(6):451-453.
14. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492-2502.
15. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology - Breast Cancer. Version 2, 2011.
16. Wolff AC, Hammond MEH, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25(1):118-145.
17. Yang XR, Chang-Claude J, Goode EL, et al. Associations of breast cancer risk factors with tumor subtypes: A pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103(3):250-263.
18. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97(6):439-448.
19. Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2- negative invasive breast cancer, the so-called triple-negative phenotype. Cancer. 2007;109(9):1721-1728.
20. Hausauer AK, Keegan THM, Chang ET, et al. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: Changes by tumor subtype. Breast Cancer Res. 2007;9(6):R90.
21. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization; 2000.
22. Hudis CA. Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med. 2007;357(1):39-51.
23. Hammond MEH, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784-2795.
24. Gomez SL, Le GM, West DW, et al. Hospital policy and practice regarding the collection of data on race, ethnicity, and birthplace. Am J Public Health. 2003;93(10):1685-1688.
25. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747-752.
26. Lund M, Trivers K, Porter P, et al. Race and triple negative threats to breast cancer survival: A population-based study in Atlanta, GA. Breast Cancer Res Treat. 2009;113(2):357-370.
27. Surveillance Research Program, National Cancer Institute. SEER*Stat software, version 7.0.5. http://www.seer.cancer.gov/seerstat. Accessed November 5, 2011.
28. Fay MP. Approximate confidence intervals for rate ratios from directly standardized rates with sparse data. Commun Stat Theory. 1999;28(9):2141-2160.
29. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol. 1995;141(4):300-304.
30. Pike MC, Spicer DV, Dahmoush L, et al. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17-30.
31. Ademuyiwa FO, Olopade OI. Racial differences in genetic factors associated with breast cancer. Cancer Metast Rev. 2003;22(1):47-53.
32. Kurian A, Fish K, Shema S, et al. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010;12(6):R99.
33. Parise CA, Bauer KR, Caggiano V. Variation in breast cancer subtypes with age and race/ethnicity. Crit Rev Oncol Hemat. 2010;76(1):44-52.
34. Lund MJ, Butler EN, Hair BY, et al. Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes. Cancer. 2010;116(11):2549-2559.
35. Millikan R, Newman B, Tse C-K, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008;109(1):123-139.
36. Stead L, Lash T, Sobieraj J, et al. Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res. 2009;11(2):R18.
37. Krieger N, Chen J, Waterman P. Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: Disparities are historically contingent, not innate. Cancer Cause Control. 2011;22(3):511-514.
38. Brinton LA, Benichou J, Gammon MD, et al. Ethnicity and variation in breast cancer incidence. Int J Cancer. 1997;73(3):349-355.
39. Trivers K, Lund M, Porter P, et al. The epidemiology of triple-negative breast cancer, including race. Cancer Cause Control. 2009;20(7):1071-1082.
40. Yin D, Morris C, Allen M, et al. Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups? Cancer Cause Control. 2010;21(10):1721-1730.
41. Levy DE, Byfield SD, Comstock CB, et al. Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk. Genet Med. 2011;13(4):349-355.
42. Chagpar AB, Polk HC Jr, McMasters KM. Racial trends in mammography rates: A population-based study. Surgery. 2008;144(3):467-472.
43. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: Survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol. 2009;27(27):4515-4521.
44. Kurian AW. BRCA1 and BRCA2 mutations across race and ethnicity: Distribution and clinical implications. Curr Opin Obstet Gyn. 2010;22(1):72-78. doi:10.1097/GCO.0b013e328332dca3.
45. Telli M, Chang E, Kurian A, et al. Asian ethnicity and breast cancer subtypes: A study from the California Cancer Registry. Breast Cancer Res Treat. 2011;127(2):471-478.
46. Keegan THM, Gomez SL, Clarke CA, et al. Recent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California. Int J Cancer. 2007;120(6):1324-1329.
47. Gomez SL, Quach T, Horn-Ross PL, et al. Hidden breast cancer disparities in Asian women: Disaggregating incidence rates by ethnicity and migrant status. Am J Public Health. 2010;100(S1):S125-131.